Baxter Follows Abbott’s Lead with Plan to Split into Two Independent Companies
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 4 (Table of Contents)
Published: 26 Apr-2014
DOI: 10.3833/pdr.v2014.i4.2020 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Turning its back on the diversified healthcare model, Baxter has announced plans to separate into two companies, one focused on biopharmaceuticals and the other on medical products...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS